Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07087015

Efficacy of Cervical Sympathetic Blocks for PTSD

Efficacy of Cervical Sympathetic Blocks for Post-traumatic Stress Disorder: a Randomized Control Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Millions of people suffer from anxiety disorders, including posttraumatic stress disorder (PTSD)-a condition that can profoundly disrupt daily life. Although treatments like therapy and medication help many, there is still a major need for more effective and faster-acting options. In recent studies, a procedure called cervical sympathetic block (CSB)-an injection near a nerve cluster in the neck-has shown promise in reducing PTSD symptoms, as measured by standardized tools like the CAPS (Clinician-Administered PTSD Scale). In this study, the investigators will conduct a double-blind, randomized controlled trial comparing CSB to a sham (placebo) injection in patients with PTSD. The investigators will assess changes in PTSD symptoms and also monitor physiological markers (like pupil response, temperature, and heart rate variability) to better understand how the treatment works and to improve the precision of future therapies.

Detailed description

The investigators aim to determine whether cervical sympathetic blocks (CSBs) can reduce symptoms of posttraumatic stress disorder (PTSD). If effective, this approach could offer a rapid, legal, and scalable intervention for mental health conditions, in contrast with emerging psychedelic therapies. This research has the potential to transform treatment practices for PTSD and related disorders by providing a controlled, procedure-based option that modulates the autonomic nervous system. In addition to assessing symptom relief, the study will explore physiologic markers of sympathetic modulation, which may help identify objective indicators of treatment success. This could deepen our understanding of the neural mechanisms underlying PTSD and mental health more broadly, with implications for neuroscience, psychology, and clinical care.

Conditions

Interventions

TypeNameDescription
PROCEDURECervical sympathetic nerve blockPatients will receive a CSB.
PROCEDURESubcutaneous sham injectionPatients will receive a subcutaneous sham injection of saline.
DRUGRopivacaineThe CSB group will receive ropivacaine 0.5% 10ml.
DRUGNormal SalineThe control group will receive 3 ml of normal saline in the sham injection.

Timeline

Start date
2025-10-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-07-25
Last updated
2025-08-26

Source: ClinicalTrials.gov record NCT07087015. Inclusion in this directory is not an endorsement.